Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia

Launched by UNIVERSITY HOSPITAL, TOULOUSE · May 16, 2018

Keywords

ClinConnect Summary

This clinical trial is studying a new way to give oxygen to patients with hypoxemic pneumonia, a serious lung infection that can make it hard to breathe and often requires hospitalization. The trial is testing an automated oxygen therapy system that adjusts the flow of oxygen based on how well the patient is breathing. This method has shown promise in helping other patients with similar breathing issues, potentially leading to shorter hospital stays and quicker recovery times.

To participate in the trial, patients need to be adults who have been hospitalized for pneumonia for less than 48 hours and are experiencing low oxygen levels. They should have symptoms like a cough, chest pain, or difficulty breathing, along with signs of fever or low body temperature. However, patients who were hospitalized for pneumonia acquired in the hospital or who have serious ongoing health issues, like chronic respiratory failure or active cancer, will not be eligible. Those who join the trial can expect close monitoring and support while receiving this innovative oxygen therapy.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult
• • Patient living at home or in an institution
• • Patient hospitalized for less than 48 hours
• * Pneumonia defined (according to the 2006 French-speaking infectious pneumology society (SPILF) criteria) by:
• • respiratory functional symptoms (cough, sputum, dyspnea, chest pain) and
• • Hyperthermia \>38,5°C or hypothermia \<36°C and
• • Radiological Signs of Pneumonia
• • Hypoxia : SpO2 \< 94% in ambient air and/or PaO2\< 60 mmHg in ambient air
• Exclusion Criteria:
• • Pneumonia acquired at the hospital.
• • Patient hospitalized in another department more than 48 hours before admission
• • Chronic respiratory failure
• • Active neoplasia
• • Patients undergoing oxygen therapy and / or long-term NIV
• • Associated cardiac decompensation (clinical signs and / or NTproBNP\> 1800ng / mL) (3
• • Initial Need for high flow oxygen therapy or ventilatory support (NIV, VI)
• • Difficulties expected from home support.